`E.I. du Pont de Nemours & Co. and
`Acher-Daniels-Midland Co. v. Furanix Technologies BV
`IPR2015-01838
`
`
`
`I, Michael W. Glynn, declare as follows:
`
`1.
`
`I am a litigation associate at the firm Kenyon & Kenyon LLP, where
`
`my practice focuses on patent—re1ated matters, and in particular, patent litigation in
`
`the pharmaceutical and chemical fields.
`
`2.
`
`I am a member in good standing of the State Bars of New York and
`
`Connecticut.
`
`3.
`
`I have five years’ experience litigating patents in the
`
`pharmaceutical/chemical field including the following cases in the District Courts
`
`of New Jersey and Delaware:
`
`0 Allergan, Inc. et al. 12. Watson Laboratories, Inc. — Florida, et al.,
`
`Civil Action No. 09—cV—05l 1,
`
`0 Reckitt Benckiser, Inc. et al. v. Tris Pharma, Inc. et al., Civil Action
`
`No. 09—cv—03 125
`
`0
`
`Intendis Gmbh et al. v. Glenmark Generics Ltd. et al., Civil Action
`
`No. 13-cv-0421,
`
`0 Novartis Pharmaceuticals Corp. et al. v. Noven Pharmaceuticals,
`
`Inc., Civil Action Nos.
`
`l3—cv—527 & l4—cv—l ll (consolidated)
`
`4.
`
`I have not been suspended or disbarred from practice before any court
`
`or administrative body.
`
`
`
`5.
`
`I have not been denied admission to practice before any court or
`
`administrative body.
`
`6.
`
`I have never been sanctioned or cited for contempt by any court or
`
`administrative body.
`
`7.
`
`I applied for, and was granted, pro hac vice admission in IPR20l4—
`
`00784 (which was joined with IPR2015—005 1 8).
`
`8.
`
`I am familiar with the subject matter of this proceeding. I have read
`
`and am familiar with the subject U.S. Patent 8,865,921 and its prosecution history.
`
`I have read and am familiar with all papers and exhibits filed by Petitioners and
`
`Patent Owner in this proceeding.
`
`9.
`
`Given my familiarity with the subject matter of this proceeding and
`
`my litigation experience, I have experience and expertise important to representing
`
`Patent Owner Furanix Technologies B.V. in this matter.
`
`10.
`
`I have read and will comply with the Office Patent Trial Practice
`
`Guide and the Board’s Rules of Practice for Trials set forth in part 42 of 37 C.F.R.
`
`11.
`
`I have read and will comply with and be subject to the United States
`
`Patent and Trademark Office Rules of Professional Conduct set forth in 37 C.F.R.
`
`§§ 11.101 et. seq. and disciplinary jurisdiction under 37 C.F.R. § 1 l.19(a).
`
`I declare that all statements made herein of my knowledge are true and that
`
`all statements made on information and belief are believed to be true, and further
`
`
`
`that these statements are made with knowledge that Wlllfill false statements and the 1
`
`like are punishable by fine or imprisonment, or both, under § 1001 of Title 18 of
`
`the United States Code.
`
`Dated: September 18, 2015
`
`Respectfully submitted,
`
`Michael W. Glynn,
`
`KENYON & KENYON LLP
`
`One Broadway
`New York, NY 10004-1007
`Tel: 212-425-7200
`
`Fax: 212-425-5288
`
`Counselfor Patent Owner Furanix
`Technologies B. V.